+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Opsonic and protective activity of five human IgM monoclonal antibodies reactive with lipopolysaccharide antigen of Pseudomonas aeruginosa



Opsonic and protective activity of five human IgM monoclonal antibodies reactive with lipopolysaccharide antigen of Pseudomonas aeruginosa



Fems Microbiology Immunology 2(5-6): 263-268



International Antigen Typing Schema (IATS) serotypes 1, 2, 5, 6, 8 and 11 comprise approximately 80% of Pseudomonas aeruginosa strains isolated from blood, wounds and respiratory specimens. Five human immunoglobulin M (IgM) monoclonal antibodies (MAbs) reactive with lipopolysaccharide O antigens of these IATS serotypes were studied in an opsonophagocytic assay. The assay employed human polymorphonuclear leukocytes, 2% guinea pig serum as the complement source and MAb. Each MAb promoted killing of inoculum of the homologous LPS serotype. The opsonic activity of each MAb was complement-dependent. In a murine model of Pseudomonas burn wound sepsis the LD50 of five strains of P. aeruginosa was increased greater than or equal to 22-fold by MAb-treatment (1.0 mg/kg). The mean effective dose of the five MAbs in mice challenged with approximately 10 LD50 of the homologous LPS serotype ranged from less than 0.01 mg/kg to 1.00 mg/kg.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 032649170

Download citation: RISBibTeXText

PMID: 2127368

DOI: 10.1111/j.1574-6968.1990.tb03528.x


Related references

Human monoclonal antibodies against Pseudomonas aeruginosa lipopolysaccharide derived from transgenic mice containing megabase human immunoglobulin loci are opsonic and protective against fatal pseudomonas sepsis. Infection and Immunity 69(4): 2223-2229, 2001

Opsonic killing and mouse protective activity of monoclonal mab and polyclonal human immunoglobulin g m and a specific for pseudomonas aeruginosa lipopolysaccharide lps. Abstracts of the Annual Meeting of the American Society for Microbiology 88: 49, 1988

Murine monoclonal antibodies against core determinants of international type 6 pseudomonas aeruginosa lipopolysaccharide are opsonic and protective. Abstracts of the Annual Meeting of the American Society for Microbiology 85: 41, 1985

Opsonic and protective monoclonal antibodies mab directed to pseudomonas aeruginosa lps fail to prevent chronic pa pneumonia. Pediatric Research 25(4 Part 2): 190A, 1989

Monoclonal antibodies cross-reactive and cross-protective against human monoclonal antibodies against pseudomonas aeruginosa serotypes. Official Gazette of the United States Patent & Trademark Office Patents 1198(1): 388, 1997

Protective monoclonal antibodies to pseudomonas aeruginosa following immunization with antigen from a single pseudomonas serotype. International Society Of Blood Transfusion Abstracts Of The Congress Of The International Society Of Blood Transfusion, No 18 Symposium; Munich, West Germany, July 22-27, 240p S Karger: Basel, Switzerland; New York, N Y , Usa Illus Paper 177, 1984

Production and characterisation of mouse monoclonal antibodies reactive with the lipopolysaccharide core of Pseudomonas aeruginosa. Journal of Medical Microbiology 36(5): 358-365, 1992

Activity of anti-lipopolysaccharide human IgM monoclonal antibodies in the treatment of Pseudomonas aeruginosa-Staphylococcus aureus polymicrobic cellulitis. Serodiagnosis and ImmunoTherapy in Infectious Disease 3(4): 225-230, 1989

Inhibitory activity on bacterial motility and in vivo protective activity of human monoclonal antibodies against flagella of Pseudomonas aeruginosa. Infection and Immunity 59(2): 550-554, 1991

Hem agglutinating opsonic and protective antibodies to pseudomonas aeruginosa in pooled human immuno globulin g modified for intra venous use in man. Clinical Research 29(2): 394A, 1981

Human monoclonal antibody against Pseudomonas aeruginosa LPS derived from transgenic XenoMouseTM mice is opsonic and highly protective in the neutropenic mouse model of sepis. Clinical Infectious Diseases 31(1): 213, 2000

Effect of human monoclonal antibody against O-antigen and core-antigen of lipopolysaccharide on gut-derived Pseudomonas aeruginosa sepsis in mice. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 43: 66, 2003

Protective activity of antibodies to exotoxin A and lipopolysaccharide at the onset of Pseudomonas aeruginosa septicemia in man. Journal of Clinical Investigation 63(2): 276-286, 1979

A protective human monoclonal antibody directed to the outer core region of Pseudomonas aeruginosa lipopolysaccharide. Infection and Immunity 59(1): 1-6, 1991

Specificity and function of murine monoclonal antibodies and immunization-induced human polyclonal antibodies to lipopolysaccharide subtypes of Pseudomonas aeruginosa serogroup 06. Infection and Immunity 62(4): 1137-1143, 1994